$304 Million is the total value of Iguana Healthcare Management, LLC's 64 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 108.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SELECT SECTOR SPDR TRput | $36,016,000 | – | 500,000 | +100.0% | 11.85% | – | |
| CELG | Buy | CELGENE CORP | $23,952,000 | +146.0% | 200,000 | +122.2% | 7.88% | +105.8% |
| CI | Buy | CIGNA CORPORATION | $19,755,000 | +265.8% | 135,000 | +237.5% | 6.50% | +206.0% |
| AMGN | Buy | AMGEN INC | $16,233,000 | +80.5% | 100,000 | +53.8% | 5.34% | +51.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $12,901,000 | +21.8% | 115,000 | +4.5% | 4.24% | +1.9% |
| BAX | New | BAXTER INTL INC | $12,399,000 | – | 325,000 | +100.0% | 4.08% | – |
| MYL | Buy | MYLAN N V | $12,166,000 | +174.7% | 225,000 | +104.5% | 4.00% | +129.8% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $9,846,000 | +74.4% | 150,000 | +50.0% | 3.24% | +45.9% |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $9,016,000 | +334.7% | 400,000 | +220.0% | 2.97% | +263.6% |
| XLRN | Buy | ACCELERON PHARMA INC | $7,314,000 | +167.0% | 150,000 | +36.4% | 2.41% | +123.5% |
| MRK | New | MERCK & CO INC NEW | $5,282,000 | – | 100,000 | +100.0% | 1.74% | – |
| ENDP | Buy | ENDO INTL PLC | $4,592,000 | -5.3% | 75,000 | +7.1% | 1.51% | -20.8% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,259,000 | +374.3% | 353,161 | +370.9% | 1.40% | +296.9% |
| MDRX | Buy | ALLSCRIPTS HEALTHCARE SOLUTN | $4,230,000 | +31.2% | 275,000 | +5.8% | 1.39% | +9.8% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $4,214,000 | +15.3% | 60,687 | +51.7% | 1.39% | -3.5% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $3,858,000 | – | 100,000 | +100.0% | 1.27% | – |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $3,840,000 | – | 50,000 | +100.0% | 1.26% | – |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $3,761,000 | +55.0% | 175,000 | +16.7% | 1.24% | +29.6% |
| CYTK | New | CYTOKINETICS INC | $3,661,000 | – | 350,000 | +100.0% | 1.20% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $3,556,000 | +29.8% | 110,000 | +69.2% | 1.17% | +8.5% |
| HTWR | New | HEARTWARE INTL INC | $3,528,000 | – | 70,000 | +100.0% | 1.16% | – |
| EVHC | New | ENVISION HEALTHCARE HLDGS IN | $3,246,000 | – | 125,000 | +100.0% | 1.07% | – |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $3,060,000 | +86.2% | 150,000 | +20.0% | 1.01% | +55.9% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $2,915,000 | +72.2% | 50,000 | +25.0% | 0.96% | +44.0% |
| HWAY | Buy | HEALTHWAYS INC | $2,896,000 | +62.8% | 225,000 | +40.6% | 0.95% | +36.1% |
| BKD | Buy | BROOKDALE SR LIVING INC | $2,769,000 | +100.9% | 150,000 | +150.0% | 0.91% | +68.1% |
| New | ZIMMER BIOMET HLDGS INCcall | $2,565,000 | – | 25,000 | +100.0% | 0.84% | – | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $2,354,000 | +95.4% | 25,000 | +66.7% | 0.78% | +63.5% |
| New | STRYKER CORPcall | $2,324,000 | – | 25,000 | +100.0% | 0.76% | – | |
| THC | New | TENET HEALTHCARE CORP | $2,273,000 | – | 75,000 | +100.0% | 0.75% | – |
| ZGNX | New | ZOGENIX INC | $2,211,000 | – | 150,000 | +100.0% | 0.73% | – |
| RDUS | New | RADIUS HEALTH INC | $2,154,000 | – | 35,000 | +100.0% | 0.71% | – |
| RXDX | Buy | IGNYTA INC | $2,144,000 | +95.3% | 160,000 | +28.0% | 0.70% | +63.2% |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $2,140,000 | – | 75,000 | +100.0% | 0.70% | – |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $2,016,000 | +6.4% | 150,000 | +11.1% | 0.66% | -11.0% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $1,960,000 | – | 25,000 | +100.0% | 0.64% | – |
| SGMO | New | SANGAMO BIOSCIENCES INC | $1,826,000 | – | 200,000 | +100.0% | 0.60% | – |
| DEPO | New | DEPOMED INC | $1,813,000 | – | 100,000 | +100.0% | 0.60% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $1,722,000 | – | 75,000 | +100.0% | 0.57% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $1,699,000 | – | 60,000 | +100.0% | 0.56% | – |
| New | ILLUMINA INCput | $1,440,000 | – | 7,500 | +100.0% | 0.47% | – | |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $1,250,000 | +18.1% | 200,000 | +60.0% | 0.41% | -1.2% |
| IMMU | New | IMMUNOMEDICS INC | $1,228,000 | – | 400,000 | +100.0% | 0.40% | – |
| New | ONCOMED PHARMACEUTICALS INCcall | $1,127,000 | – | 50,000 | +100.0% | 0.37% | – | |
| SPNC | New | SPECTRANETICS CORP | $753,000 | – | 50,000 | +100.0% | 0.25% | – |
| PPHM | Buy | PEREGRINE PHARMACEUTICALS IN | $585,000 | +63.9% | 500,000 | +42.9% | 0.19% | +37.1% |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $312,000 | – | 25,000 | +100.0% | 0.10% | – |
| MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $254,000 | – | 25,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.